Remove Heart Valves Remove Hospital Remove Tricuspid
article thumbnail

Columbia Cardiology Launches New Mitral & Tricuspid Center

DAIC

Columbia University Irving Medical Center’s Division of Cardiology has announced its launch of the Mitral & Tricuspid Center. Kodali, MD, pictured here, is one of the members of its leadership team, and director of the Structural Heart and Valve Center at CUIMC/NewYork-Presbyterian Hospital.

Tricuspid 111
article thumbnail

TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replacement System in Patient with a Pacemaker

DAIC

Tricuspid regurgitation (TR) is a common and serious disease for which open heart surgery and symptomatic pharmacologic treatment are the current standard treatment options. Topaz is an innovative, minimally invasive device designed specifically to help patients suffering from severe TR, without the need for open heart surgery.

article thumbnail

Henry Ford Health Heart Failure Patient First in Michigan to Receive Breakthrough Device

DAIC

Henry Ford Health's Center for Structural Heart Disease team delivered its first in Michigan FDA-approved VOQUE Transcatheter Tricuspid Valve Replacement System to a heart failure patient on February 13, 2024 at Henry Ford Hospital in Detroit. million Americans have moderate to severe tricuspid regurgitation.

article thumbnail

MUSC Health team 1st in US to implant new heart valve

Becker's Hospital Review - Cardiology

based MUSC Health's Heart and Vascular Center became the first in the country to implant the Topaz device, a new transcatheter tricuspid heart valve replacement system. A team from Charleston, S.C.-based

article thumbnail

Columbia Cardiology Launches New Mitral and Tricuspid Center

DAIC

Columbia University Irving Medical Center’s Division of Cardiology has announced its launch of the Mitral & Tricuspid Center. Kodali, MD, pictured here, is one of the members of its leadership team, and director of the Structural Heart and Valve Center at CUIMC/NewYork-Presbyterian Hospital.

article thumbnail

Taskforce Develops New Standards to Monitor Adults with Heart Valve Disease

DAIC

Highlights include: Due to the aging population and improvement in diagnostic strategies, the prevalence of heart valve disease is expected to double by 2040 and triple by 2060.As As a result, it is estimated that the number of patients requiring heart valve interventions will increase significantly in the coming decades.

article thumbnail

Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves

Circulation: Cardiovascular Interventions

The study aims to compare the outcomes of transcatheter aortic valve replacement for AS in patients with type 0 bicuspid, type 1 bicuspid, and tricuspid aortic valve anatomy.METHODS:We enrolled consecutive patients undergoing transcatheter aortic valve replacement for severe AS between 2012 and 2022 in this single-center retrospective cohort study.